|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:NKD1-BRD7 (FusionGDB2 ID:59266) |
Fusion Gene Summary for NKD1-BRD7 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NKD1-BRD7 | Fusion gene ID: 59266 | Hgene | Tgene | Gene symbol | NKD1 | BRD7 | Gene ID | 85407 | 29117 |
| Gene name | NKD inhibitor of WNT signaling pathway 1 | bromodomain containing 7 | |
| Synonyms | Naked1 | BP75|CELTIX1|NAG4 | |
| Cytomap | 16q12.1 | 16q12.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein naked cuticle homolog 1Dvl-binding proteinNKD1, WNT signaling pathway inhibitornaked cuticle homolog 1naked cuticle-1naked-1 | bromodomain-containing protein 775 kDa bromodomain proteinprotein CELTIX-1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q969G9 | Q9NPI1 | |
| Ensembl transtripts involved in fusion gene | ENST00000564336, ENST00000268459, | ENST00000394688, ENST00000394689, ENST00000401491, | |
| Fusion gene scores | * DoF score | 7 X 4 X 6=168 | 5 X 5 X 3=75 |
| # samples | 8 | 5 | |
| ** MAII score | log2(8/168*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: NKD1 [Title/Abstract] AND BRD7 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | NKD1(50583466)-BRD7(50388833), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | BRD7 | GO:0006357 | regulation of transcription by RNA polymerase II | 12489984 |
| Tgene | BRD7 | GO:0008285 | negative regulation of cell proliferation | 20228809 |
| Tgene | BRD7 | GO:0035066 | positive regulation of histone acetylation | 20228809 |
| Tgene | BRD7 | GO:0045892 | negative regulation of transcription, DNA-templated | 16265664 |
| Tgene | BRD7 | GO:0045893 | positive regulation of transcription, DNA-templated | 20228809 |
| Tgene | BRD7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 16265664 |
| Fusion gene breakpoints across NKD1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across BRD7 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-AO-A0JE-01A | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
Top |
Fusion Gene ORF analysis for NKD1-BRD7 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3CDS | ENST00000564336 | ENST00000394688 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
| 3UTR-3CDS | ENST00000564336 | ENST00000394689 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
| 3UTR-5UTR | ENST00000564336 | ENST00000401491 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
| 5CDS-5UTR | ENST00000268459 | ENST00000401491 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
| In-frame | ENST00000268459 | ENST00000394688 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
| In-frame | ENST00000268459 | ENST00000394689 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000268459 | NKD1 | chr16 | 50583466 | + | ENST00000394688 | BRD7 | chr16 | 50388833 | - | 5368 | 416 | 134 | 2113 | 659 |
| ENST00000268459 | NKD1 | chr16 | 50583466 | + | ENST00000394689 | BRD7 | chr16 | 50388833 | - | 2298 | 416 | 134 | 2116 | 660 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000268459 | ENST00000394688 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - | 0.00040003 | 0.9996 |
| ENST00000268459 | ENST00000394689 | NKD1 | chr16 | 50583466 | + | BRD7 | chr16 | 50388833 | - | 0.002033719 | 0.9979663 |
Top |
Fusion Genomic Features for NKD1-BRD7 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NKD1-BRD7 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:50583466/chr16:50388833) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NKD1 | BRD7 |
| FUNCTION: Cell autonomous antagonist of the canonical Wnt signaling pathway. May activate a second Wnt signaling pathway that controls planar cell polarity. {ECO:0000269|PubMed:11752446, ECO:0000269|PubMed:15687260, ECO:0000269|PubMed:16567647}. | FUNCTION: Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at 'Tyr-216'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR (By similarity). Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at 'Lys-9' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at 'Lys-382', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase. {ECO:0000250, ECO:0000269|PubMed:16265664, ECO:0000269|PubMed:16475162, ECO:0000269|PubMed:20215511, ECO:0000269|PubMed:20228809, ECO:0000269|PubMed:20660729}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394688 | 1 | 17 | 536_567 | 86 | 652.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394689 | 1 | 17 | 536_567 | 86 | 653.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394688 | 1 | 17 | 148_218 | 86 | 652.0 | Domain | Bromo | |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394689 | 1 | 17 | 148_218 | 86 | 653.0 | Domain | Bromo |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | NKD1 | chr16:50583466 | chr16:50388833 | ENST00000268459 | + | 3 | 10 | 144_155 | 64 | 471.0 | Calcium binding | Ontology_term=ECO:0000255 |
| Hgene | NKD1 | chr16:50583466 | chr16:50388833 | ENST00000268459 | + | 3 | 10 | 452_466 | 64 | 471.0 | Compositional bias | Note=His-rich |
| Hgene | NKD1 | chr16:50583466 | chr16:50388833 | ENST00000268459 | + | 3 | 10 | 131_166 | 64 | 471.0 | Domain | EF-hand |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394688 | 1 | 17 | 3_91 | 86 | 652.0 | Compositional bias | Note=Lys-rich | |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394689 | 1 | 17 | 3_91 | 86 | 653.0 | Compositional bias | Note=Lys-rich | |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394688 | 1 | 17 | 65_96 | 86 | 652.0 | Motif | Nuclear localization signal | |
| Tgene | BRD7 | chr16:50583466 | chr16:50388833 | ENST00000394689 | 1 | 17 | 65_96 | 86 | 653.0 | Motif | Nuclear localization signal |
Top |
Fusion Gene Sequence for NKD1-BRD7 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >59266_59266_1_NKD1-BRD7_NKD1_chr16_50583466_ENST00000268459_BRD7_chr16_50388833_ENST00000394688_length(transcript)=5368nt_BP=416nt GCCAATGGGCGCGCGGGGAGGCGCGGGCCGCGGCGGCGGGCTGGGGGCTCGGCGCTCCCGGGCGTCAGTCGGGCCGCGGCGACGGCGGCA GGAGCGCGTCCCGGCGCCGCCTCGGGCTCCGCTCGGCTCGGGGGCTGCTTCGGGAGGAGGAGAGCCAAGGGAGGCGCCAGGCCCGCGGGC CGGGCGCATGGCTTAGGGACGCTCCCGGCCGCCGCAGCCCCAGCATGGGGAAACTTCACTCCAAGCCGGCCGCCGTGTGCAAGCGCAGGG AGAGCCCGGAAGGTGACAGCTTCGCCGTGAGCGCTGCCTGGGCTCGGAAGGGCATCGAGGAGTGGATCGGGAGACAGCGCTGCCCGGGCG GTGTCTCGGGACCCCGACAGCTGCGGTTGGCGGGCACCATAGGCCGAAGCACCCGGGAGGATAAAAAGAAGCGAGATCGAGACCGGGTGG AGAATGAGGCAGAAAAAGATCTCCAGTGTCACGCCCCTGTGAGATTAGACTTGCCTCCTGAGAAGCCTCTCACAAGCTCTTTAGCCAAAC AAGAAGAAGTAGAACAGACACCCCTTCAAGAAGCTTTGAATCAACTGATGAGACAATTGCAGAGAAAAGATCCAAGTGCTTTCTTTTCAT TTCCTGTGACTGATTTTATTGCTCCTGGCTACTCCATGATCATTAAACACCCAATGGATTTTAGTACCATGAAAGAAAAGATCAAGAACA ATGACTATCAGTCCATAGAAGAACTAAAGGATAACTTCAAACTAATGTGTACTAATGCCATGATTTACAATAAACCAGAGACCATTTATT ATAAAGCTGCAAAGAAGCTGTTGCACTCAGGAATGAAAATTCTTAGCCAGGAAAGAATTCAGAGCCTGAAGCAGAGCATAGACTTCATGG CTGACTTGCAGAAAACTCGAAAGCAGAAAGATGGAACAGACACCTCACAGAGTGGGGAGGACGGAGGCTGCTGGCAGAGAGAGAGAGAGG ACTCTGGAGATGCCGAAGCACACGCCTTCAAGAGTCCCAGCAAAGAAAATAAAAAGAAAGACAAAGATATGCTTGAAGATAAGTTTAAAA GCAATAATTTAGAGAGAGAGCAGGAGCAGCTTGACCGCATCGTGAAGGAATCTGGAGGAAAGCTGACCAGGCGGCTTGTGAACAGTCAGT GCGAATTTGAAAGAAGAAAACCAGATGGAACAACGACGTTGGGACTTCTCCATCCTGTGGATCCCATTGTAGGAGAGCCAGGCTACTGCC CTGTGAGACTGGGAATGACAACTGGAAGACTTCAGTCTGGAGTGAATACTTTGCAGGGGTTCAAAGAGGATAAAAGGAACAAAGTCACTC CAGTGTTATATTTGAATTATGGGCCCTACAGTTCTTATGCACCGCATTATGACTCCACATTTGCAAATATCAGCAAGGATGATTCTGATT TAATCTATTCAACCTATGGGGAAGACTCTGATCTTCCAAGTGATTTCAGCATCCATGAGTTTTTGGCCACGTGCCAAGATTATCCGTATG TCATGGCAGATAGTTTACTGGATGTTTTAACAAAAGGAGGGCATTCCAGGACCCTACAAGAGATGGAGATGTCATTGCCTGAAGATGAAG GCCATACTAGGACACTTGACACAGCAAAAGAAATGGAGATTACAGAAGTAGAGCCACCAGGGCGTTTGGACTCCAGTACTCAAGACAGGC TCATAGCGCTGAAAGCAGTAACAAATTTTGGCGTTCCAGTTGAAGTTTTTGACTCTGAAGAAGCTGAAATATTCCAGAAGAAACTTGATG AGACCACCAGATTGCTCAGGGAACTCCAGGAAGCCCAGAATGAACGTTTGAGCACCAGACCCCCTCCGAACATGATCTGTCTCTTGGGTC CCTCATACAGAGAAATGCATCTTGCTGAACAAGTGACCAATAATCTTAAAGAACTTGCACAGCAAGTAACTCCAGGTGATATCGTAAGCA CGTATGGAGTTCGAAAAGCAATGGGGATTTCCATTCCTTCCCCCGTCATGGAAAACAACTTTGTGGATTTGACAGAAGACACTGAAGAAC CTAAAAAGACGGATGTTGCTGAGTGTGGACCTGGTGGAAGTTGAGGCTGCCTGGTATTTGATTATATATTATGTACATACTTTTTCATTC TTAACTTAGAAATGCTTTTCAGAAGATATTAAATATTTGTAAATTGTGTTTTTAATTAAACTTTGGAACAGCGAATTTGGATGTTCCAGA GGTTGGACTTGTATTAGGTAATAAAGCTGGACCTGGGACTCGTGAGGAAGGAATGTGCTTGGGGCTGTTGCCATACCTGTGCAGCATTCT TTCAAAATAGTGCCTTCCAATGCTTCTTCCTTATGTCCCACAGACAGGATCATCACTAAGAAGCGTTCTTAAAACGGCCCCATCCAGTGA GATTTTCCGTTATACGAACATACTTGAAATAATTTTAGAATTTACTACTGTGGTTCTGCCCCTGCATACCCAGTGGGAATGATGCCCTTG TATGGGTAATTAGGCACCTCCCACCCACCCCTGACAAAAGCACACTGGGAGTTTTATAGCACTGTCACATGGCTAGTGTTCTTTTTTGGT TTTTTCCGTTTTTTAAAGAAAGAGGAGTTACTTAGTACTATAGCAAAGTAATAAGCCAAATAAGATAAACTAAGTCATCCTTGAATAGAT CAGGGAATTACCAGATTACCAAAAGGTGACATTTCTACTTTACTTACTGTTTATCTGAAATACAAAGGTCAAGTACCCAAGGAGTTGAAC TCTAAGTAGGAGACCACAAGATTCATGGCCCCCTTTTATCAGCAAGCTGAGATAAATGGTGATTTTGCTGAATCGGTATAGAACCTGTTA TACACAAGGGAAAAAAATCAGGATGGAGATAGATAGATAGATAGCCTTGTTCAGTGAACAAATTAAGTTTGAAGGCCCTTATACAATCCT TCTATAAATCACCCAGGCAGGAAGCCATTTGATTTCTATTATTTTCCTGACTTTGAAAATTAATTAGTATTTAGGAAGAACAAATAGGGT AAAGGAAAATTAATTCCCTCAAAAGACTTAAAATCTTATGCTAAAAGAGTCAAATTTTCAAGTTGTTTGAGTCTACTTTTAATCTCTAGT GAGTTCATGAGGACCACGAAAATAAAATACCTTCAGATATTTGAGTTTTTCAAATTGCTAATTTAATGTATAAAAAGCAGCTAAACACTG GTACTTTATAAAAATGAAACAGCATTTTGAAACAAATGTTACAGATCTATAAATATTCATTATATAGAATAAACCCTAGTTACTTGCATG CACCACCTCAAATCATATTTCTTTACACTGACCTATTATATACACAAAGTATACAGTGGTTAATGATCTTCTCTTCTGTTTGTTTGTTTG TTTGTTTGTTAGGAAATTTCCTCAATAAGCCAGAAAACCTTAGGTATTATTTTCACAAAAGTTAACTCAGGAGAAATTGTAAGGAAGTCC TTGACCCATGGAGAAGGTCACTGTTTGTTTGTTTGTTAGATACGTGTGTCTGTCATAAAACAAAATGACACCAGTAATTACTTGGTAATT TAAAAACAAGTTCATAAAAAGAAAATACCTGCAGGTAATTTTTATGGTCAGTTATATTCTATAACCTGAACACTGAAAACTAAAAACTTT TACTTACAAACTATTATTATCTGAGCACAGCACAGTGCTTTGCTTTAATTGGAAATAAAAATGCATGAGTGAGTGGTAGTCAGTTATTTG TTAAACTCCCAACTGGGGTTTCTGTTGTTACTGAAGAAAAAAACAAATATTCCAAGAGTACAAATATGCTGACCTCAGAGAGGCCCAGTG CACTAATGTGTTTCTATGTTATATTAGCAACAGAAACCTTCCTGACTTGCCAGGAGAGCCCCCGCCGGGCAGCCCTGGTCACTGCTAGAT CTTGAGAGCACAGATTTCAGTATAGTATTCATGTGAAACCAGCCCTTCATGTAAAAAGTTTTGGTGTGTAAAAAAGGCAACTTAAGCGAG GCTAATTGCCCTTACCAGCATTGTTGCCATGAAATTCCTTTATACAGCAAGTTCTTCTATTCATACTGATTCCACTTATGTGCAGCACAT GAGAGCTGCCACTAGTCTACCCAGCACCTTTGTGCAAATTAGAATACACCTGCCCTTCCTCGGGCTGATAAAGCCACACGACACAGCACA GGCAGACAGGTTCAATTTTCGTTCCCTCCACCGCCACCCCCGCACTTAGCTGTACTCTTAATTTGCAGCCCGGGGCAACTCATCCCAGGA CCCCAACAAGTCTGGTCAGTCACCCAATCTGCAACCCTGTATAATCATCTTGTAAAGGCTCCTGTATGCAAGACTTTGTGTAGAACTTTA CGGGGTTCATGGGGACACCTAGCTAAGAATCCCTGCTATGTAGGGAAACTGAGTGCATTAGAAATCCTGGCGATGCTCTGGTGATGAGGC CACCGGTTAAGTCTTCCGGTTATGAAGTCCATTCAGAAAAAGTCACGGGCAGTTTGGTCATTTCTCACCCTGTTGTTACAGTTAGGTTGA CTTTCAATTCCTTGGGAAGTTGAAGCACAGTAAGACACATCCCCAAAACCTGGCTTTTTGCATTTGCCTTGACTCACGCAGTTTCAGAGC AAGAACGGCTCAGCATTTGTGAGGGGGCGGGCTTCCCAGATCCAGGAGCCTCTGCATGCACCCATGCGGAGTAGATCCTTCTAGTTTTGA AGCTCTCCAGAGTTAGCTGTGAAGACTAAAGGAAAGAAGAGATGCACTCACAGGTTGTCCAAGTTGTCTCTAAACAGACTCCATTCCTTT CTGGTAAGAAAAGTAAGATACAGTTGAAGGACGGCAGGGGAGAACGCAAAGATGTGTGAGTAATCAAGGAAGAGGTGAAAGGCCGCACCT TACTTTCAAAGCACCTCTCTCCAGAATGCTTGCCTCACAAGCTGCCTCATTCAAAGGCAAGGCTCTGCTGCTCCCCGCCTTCTTGCTGTG ACCACATTCCTCAGGACTCTATCCCCACAGCCAGCTGACCCCATAAGCTGATGCTAGACAGTAGTCCTCCTTACATGTCAGTGGTTAAAA AGGCAGAGCATACACTGGAGGGAAGAGATTTATGTCTAGTGTCTGAAAAGTCATTCAAAAGGATAAAAACCCCATTAATGTATTCATTTA AAACAAACATGCCAGACAAGGCAAAAAGTAACAGTGTTAATTGTGGTGTTTTTCTCTCTACCTGTTTGAAACCGTTTACAGATGTAAAAC >59266_59266_1_NKD1-BRD7_NKD1_chr16_50583466_ENST00000268459_BRD7_chr16_50388833_ENST00000394688_length(amino acids)=659AA_BP=10 MLREEESQGRRQARGPGAWLRDAPGRRSPSMGKLHSKPAAVCKRRESPEGDSFAVSAAWARKGIEEWIGRQRCPGGVSGPRQLRLAGTIG RSTREDKKKRDRDRVENEAEKDLQCHAPVRLDLPPEKPLTSSLAKQEEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMII KHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADLQKTRKQKDGTDT SQSGEDGGCWQREREDSGDAEAHAFKSPSKENKKKDKDMLEDKFKSNNLEREQEQLDRIVKESGGKLTRRLVNSQCEFERRKPDGTTTLG LLHPVDPIVGEPGYCPVRLGMTTGRLQSGVNTLQGFKEDKRNKVTPVLYLNYGPYSSYAPHYDSTFANISKDDSDLIYSTYGEDSDLPSD FSIHEFLATCQDYPYVMADSLLDVLTKGGHSRTLQEMEMSLPEDEGHTRTLDTAKEMEITEVEPPGRLDSSTQDRLIALKAVTNFGVPVE VFDSEEAEIFQKKLDETTRLLRELQEAQNERLSTRPPPNMICLLGPSYREMHLAEQVTNNLKELAQQVTPGDIVSTYGVRKAMGISIPSP -------------------------------------------------------------- >59266_59266_2_NKD1-BRD7_NKD1_chr16_50583466_ENST00000268459_BRD7_chr16_50388833_ENST00000394689_length(transcript)=2298nt_BP=416nt GCCAATGGGCGCGCGGGGAGGCGCGGGCCGCGGCGGCGGGCTGGGGGCTCGGCGCTCCCGGGCGTCAGTCGGGCCGCGGCGACGGCGGCA GGAGCGCGTCCCGGCGCCGCCTCGGGCTCCGCTCGGCTCGGGGGCTGCTTCGGGAGGAGGAGAGCCAAGGGAGGCGCCAGGCCCGCGGGC CGGGCGCATGGCTTAGGGACGCTCCCGGCCGCCGCAGCCCCAGCATGGGGAAACTTCACTCCAAGCCGGCCGCCGTGTGCAAGCGCAGGG AGAGCCCGGAAGGTGACAGCTTCGCCGTGAGCGCTGCCTGGGCTCGGAAGGGCATCGAGGAGTGGATCGGGAGACAGCGCTGCCCGGGCG GTGTCTCGGGACCCCGACAGCTGCGGTTGGCGGGCACCATAGGCCGAAGCACCCGGGAGGATAAAAAGAAGCGAGATCGAGACCGGGTGG AGAATGAGGCAGAAAAAGATCTCCAGTGTCACGCCCCTGTGAGATTAGACTTGCCTCCTGAGAAGCCTCTCACAAGCTCTTTAGCCAAAC AAGAAGAAGTAGAACAGACACCCCTTCAAGAAGCTTTGAATCAACTGATGAGACAATTGCAGAGAAAAGATCCAAGTGCTTTCTTTTCAT TTCCTGTGACTGATTTTATTGCTCCTGGCTACTCCATGATCATTAAACACCCAATGGATTTTAGTACCATGAAAGAAAAGATCAAGAACA ATGACTATCAGTCCATAGAAGAACTAAAGGATAACTTCAAACTAATGTGTACTAATGCCATGATTTACAATAAACCAGAGACCATTTATT ATAAAGCTGCAAAGAAGCTGTTGCACTCAGGAATGAAAATTCTTAGCCAGGAAAGAATTCAGAGCCTGAAGCAGAGCATAGACTTCATGG CTGACTTGCAGAAAACTCGAAAGCAGAAAGATGGAACAGACACCTCACAGAGTGGGGAGGACGGAGGCTGCTGGCAGAGAGAGAGAGAGG ACTCTGGAGATGCCGAAGCACACGCCTTCAAGAGTCCCAGCAAAGAAAATAAAAAGAAAGACAAAGATATGCTTGAAGATAAGTTTAAAA GCAATAATTTAGAGAGAGAGCAGGAGCAGCTTGACCGCATCGTGAAGGAATCTGGAGGAAAGCTGACCAGGCGGCTTGTGAACAGTCAGT GCGAATTTGAAAGAAGAAAACCAGATGGAACAACGACGTTGGGACTTCTCCATCCTGTGGATCCCATTGTAGGAGAGCCAGGCTACTGCC CTGTGAGACTGGGAATGACAACTGGAAGACTTCAGTCTGGAGTGAATACTTTGCAGGGGTTCAAAGAGGATAAAAGGAACAAAGTCACTC CAGTGTTATATTTGAATTATGGGCCCTACAGTTCTTATGCACCGCATTATGACTCCACATTTGCAAATATCAGCAAGGATGATTCTGATT TAATCTATTCAACCTATGGGGAAGACTCTGATCTTCCAAGTGATTTCAGCATCCATGAGTTTTTGGCCACGTGCCAAGATTATCCGTATG TCATGGCAGATAGTTTACTGGATGTTTTAACAAAAGGAGGGCATTCCAGGACCCTACAAGAGATGGAGATGTCATTGCCTGAAGATGAAG GCCATACTAGGACACTTGACACAGCAAAAGAAATGGAGCAGATTACAGAAGTAGAGCCACCAGGGCGTTTGGACTCCAGTACTCAAGACA GGCTCATAGCGCTGAAAGCAGTAACAAATTTTGGCGTTCCAGTTGAAGTTTTTGACTCTGAAGAAGCTGAAATATTCCAGAAGAAACTTG ATGAGACCACCAGATTGCTCAGGGAACTCCAGGAAGCCCAGAATGAACGTTTGAGCACCAGACCCCCTCCGAACATGATCTGTCTCTTGG GTCCCTCATACAGAGAAATGCATCTTGCTGAACAAGTGACCAATAATCTTAAAGAACTTGCACAGCAAGTAACTCCAGGTGATATCGTAA GCACGTATGGAGTTCGAAAAGCAATGGGGATTTCCATTCCTTCCCCCGTCATGGAAAACAACTTTGTGGATTTGACAGAAGACACTGAAG AACCTAAAAAGACGGATGTTGCTGAGTGTGGACCTGGTGGAAGTTGAGGCTGCCTGGTATTTGATTATATATTATGTACATACTTTTTCA TTCTTAACTTAGAAATGCTTTTCAGAAGATATTAAATATTTGTAAATTGTGTTTTTAATTAAACTTTGGAACAGCGAATTTGGATGTTCC >59266_59266_2_NKD1-BRD7_NKD1_chr16_50583466_ENST00000268459_BRD7_chr16_50388833_ENST00000394689_length(amino acids)=660AA_BP=10 MLREEESQGRRQARGPGAWLRDAPGRRSPSMGKLHSKPAAVCKRRESPEGDSFAVSAAWARKGIEEWIGRQRCPGGVSGPRQLRLAGTIG RSTREDKKKRDRDRVENEAEKDLQCHAPVRLDLPPEKPLTSSLAKQEEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMII KHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADLQKTRKQKDGTDT SQSGEDGGCWQREREDSGDAEAHAFKSPSKENKKKDKDMLEDKFKSNNLEREQEQLDRIVKESGGKLTRRLVNSQCEFERRKPDGTTTLG LLHPVDPIVGEPGYCPVRLGMTTGRLQSGVNTLQGFKEDKRNKVTPVLYLNYGPYSSYAPHYDSTFANISKDDSDLIYSTYGEDSDLPSD FSIHEFLATCQDYPYVMADSLLDVLTKGGHSRTLQEMEMSLPEDEGHTRTLDTAKEMEQITEVEPPGRLDSSTQDRLIALKAVTNFGVPV EVFDSEEAEIFQKKLDETTRLLRELQEAQNERLSTRPPPNMICLLGPSYREMHLAEQVTNNLKELAQQVTPGDIVSTYGVRKAMGISIPS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NKD1-BRD7 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | NKD1 | chr16:50583466 | chr16:50388833 | ENST00000268459 | + | 3 | 10 | 125_190 | 64.0 | 471.0 | DVL1%2C DVL2 and DVL3 |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NKD1-BRD7 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NKD1-BRD7 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies